Key result
ITPKC rs7251246 CC/CT genotype linked to ~109% higher CAA risk in Kawasaki disease vs TT.
Why the study?
The relationship between the ITPKC rs7251246 polymorphism and the severity and susceptibility to Kawasaki disease in the Southern Han Chinese population was unclear.
Does the ITPKC rs7251246 T>C polymorphism affect the risk of Kawasaki disease susceptibility, coronary artery aneurysms, and thrombosis in Han Chinese children?
Case-Control (n=483)
No
Does the ITPKC rs7251246 T>C polymorphism affect the risk of Kawasaki disease susceptibility, coronary artery aneurysms, and thrombosis in Han Chinese children?
Odds Ratio: 2.089 (95% CI 1.085–4.02)
p-value: p=0.027
The ITPKC rs7251246 T>C polymorphism is associated with an increased risk of coronary artery aneurysms and thrombosis in Southern Han Chinese children with Kawasaki disease, suggesting a potential role for genotype-guided antiplatelet therapy.
Objectives Kawasaki disease (KD) is a commonly acquired pediatric systemic vasculitis disease resulting in coronary artery aneurysm (CAA). The relationship between the ITPKC polymorphism (rs7251246) and the severity and susceptibility to KD in the Han Chinese population in Southern China remains unclear. Methods We enrolled 262 children as controls and 221 children with KD (46 [20.8%] with intravenous immunoglobulin resistance and 82 [37.1%] with CAA). The relationship between the ITPKC rs7251246 polymorphism, KD susceptibility, and CAA formation was investigated. Results While the ITPKC rs7251246 T>C polymorphism was not significantly associated with KD susceptibility, it was significantly related to the CAA risk in children with KD [CC/CT vs. TT: adjusted odds ratio [OR] 2.089, 95% confidence interval [CI] 1.085–4.020]. Male children with the rs7251246 CT/TT genotype had a significantly lower risk of thrombosis [CT/TT vs. CC: adjusted OR 0.251, 95% CI 0.068–0.923]. Children with KD, especially those with CAA, had significantly downregulated ITPKC mRNA compared to healthy children. ITPKC mRNA levels were lower in children with CAA who developed thrombosis ( P =0.039). In children with KD, the CC genotype showed lower mRNA levels of ITPKC ( P =0.035). Conclusion The ITPKC rs7251246 T>C polymorphism may be a risk factor for CAA and thrombosis in children with KD in the Han Chinese population, likely due to differences in mature mRNA levels caused by interference of RNA splicing. Dual antiplatelet therapy for thrombosis is recommended for male children with the rs7251246 CC genotype.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) conducted a case-control in Kawasaki disease (n=483). ITPKC rs7251246 CC/CT genotype vs. TT genotype was evaluated on Coronary artery aneurysm (CAA) formation (adjusted OR 2.089, 95% CI 1.085-4.020, p=0.027). The ITPKC rs7251246 CC/CT genotype significantly increased the risk of coronary artery aneurysms in children with Kawasaki disease compared to the TT genotype (adjusted OR 2.089).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: